News & Events

We are pleased to announce that Acertys Healthcare and Duomed, both active as partners in total solutions for medical devices, implants, consumables and IT solutions, will join forces and continue their activities as Duomed Belgium from the 1st of June 2022 onwards.

Duomed Group makes a difference to customers every day thanks to our employees / experts who go the extra mile day in and day out. For us, the story doesn't stop with the delivery of our products. Our Account Manager Urology, Gynaecology and Plastic Surgery, Olivier Spaas, takes you behind the scenes of his department.

Duomed Group makes a difference to customers every day thanks to our employees / experts who go the extra mile day in and day out. For us, the story doesn't stop with the delivery of our products. Our Division Director, Geert Kuys, takes you behind the scenes of our Division Surgical & Interventional.

Duomed Group makes a difference to customers every day thanks to our employees / experts who go the extra mile day in and day out. For us, the story doesn't stop with the delivery of our products. Our Business Unit Manager, Nicolas Barvais, takes you behind the scenes of our business units Endoscopy and Medical Imaging.

Prospectively collected data from the Danish hernia registry with a follow-up of more than 10 years show considerable benefits of DynaMesh®-IPOM meshes

Duomed Group makes a difference to customers every day thanks to our employees / experts who go the extra mile day in and day out. For us, the story doesn't stop with the delivery of our products. Our Sales & Application Specialist, Stef Thielemans, takes you behind the scenes of our business unit Diagnostic Care Cardiology.

Our Duomed Group employees go the extra mile for their customers and partners on a daily basis. We put some of our experts in front of the camera to share their personal stories and experiences.

The study offers the possibility of subjecting the project to an independent scientific review in order to confirm the sustainable healing success through the use of the fully autologously obtained OBSiDiAN ASG® BioMatrix in a randomized controlled trial.

First study published shows significantly reduced anastomotic leakage rate through the use of OBSiDiAN ASG®.